Anbio Biotechnology Class... (NNNN)
NASDAQ: NNNN
· Real-Time Price · USD
51.54
1.40 (2.79%)
At close: Aug 15, 2025, 11:49 AM
Anbio Biotechnology Class A Ordinary Shares Revenue
Anbio Biotechnology Class A Ordinary Shares reported an annual revenue of $8.19M, reflecting a 21.95% growth. For the quarter ending December 31, 2024, Anbio Biotechnology Class A Ordinary Shares generated $2.53M in revenue.
Revenue (ttm)
8.19M
Revenue Growth
21.95%
Price / Sales Ratio
29.81
Revenue / Employee
303.15K
Employees
27
Market Cap
2.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|